Evidence map›Paper›PMID 41896315›Full record

ArticleDiabetologia2026

Post-OGTT hypoglycaemia in newly diagnosed type 2 diabetes: frequency, characteristics and cluster assignment.

Rebecca Spies, Gisa Ufer, Roza Sabia, Julia Hummel, Andreas Peter, Robert Wagner, Martin Heni

Abstract read
In one paragraph

Article in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rebecca SpiesDivision of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0009-0007-8452-2744
Gisa UferDivision of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Roza SabiaDivision of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.
Julia HummelDivision of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-9724-8365
Andreas PeterInstitute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0001-5732-2287
Robert WagnerGerman Center for Diabetes Research (DZD), Neuherberg, Germany.ORCID http://orcid.org/0000-0002-6120-0191
Martin HeniDivision of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany. martin.heni@uniklinik-ulm.de.ORCID http://orcid.org/0000-0002-8462-3832

Funding

ERC Consolidator grant ERC Consolidator grant (CrossPeriBrainERC Consolidator grant Project 10
6 · The paper itself

Abstract

aims/hypothesisThe aim of this study was to assess the frequency and metabolic characteristics of post-OGTT hypoglycaemia during an OGTT in individuals newly diagnosed with type 2 diabetes.

methodsWe analysed 97 extended (180 min) 75 g OGTTs from individuals newly diagnosed with type 2 diabetes. Glucose, insulin and C-peptide were measured at fasting and post-challenge time points. Insulin sensitivity was assessed using the oral glucose insulin sensitivity (OGIS) index and beta cell function was measured using the insulinogenic index (IGI) and Stumvoll's second-phase index. All participants were assigned to the Ahlqvist diabetes clusters.

resultsPost-OGTT hypoglycaemia (glucose ≤3.9 mmol/l at 180 min) occurred in 8.2% of the OGTTs analysed. Compared with individuals without hypoglycaemia, individuals with post-OGTT hypoglycaemia had a significantly lower BMI and higher insulin sensitivity, without differences in beta cell function. All individuals with hypoglycaemia were assigned to the mild obesity- or age-related diabetes Ahlqvist clusters. CONCLUSIONS/

interpretationPost-OGTT hypoglycaemia is present in a subset of individuals newly diagnosed with type 2 diabetes and is associated with higher insulin sensitivity.

Indexed as

Diabetes Mellitus, Type 2HypoglycemiaAdultBlood GlucoseC-PeptideFemaleGlucose Tolerance TestHumansInsulinInsulin ResistanceInsulin-Secreting CellsMaleMiddle AgedBlood GlucoseC-PeptideInsulinDiabetes subtypesInsulin sensitivityOral glucose tolerance testPost-OGTT hypoglycaemiaReactive hypoglycaemiaType 2 diabetes

Identifiers

PMID41896315
PMCPMC13236820

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.